Pieris Pharmaceuticals (NASDAQ:PIRS) Now Covered by Analysts at StockNews.com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com assumed coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note published on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of PIRS stock opened at $11.68 on Monday. The stock’s 50-day moving average is $13.73 and its two-hundred day […]
StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research report sent to investors on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of NASDAQ:PIRS opened at $12.04 on Friday. Pieris Pharmaceuticals has a twelve month low of $10.89 and a […]
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS – Get Free Report)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $12.00, but opened at $11.71. Pieris Pharmaceuticals shares last traded at $11.30, with a volume of 14,761 shares traded. Wall Street Analysts Forecast Growth Separately, StockNews.com initiated coverage on shares of […]
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS – Get Free Report)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $12.00, but opened at $11.71. Pieris Pharmaceuticals shares last traded at $11.30, with a volume of 14,761 shares traded. Wall Street Analysts Forecast Growth Separately, StockNews.com started coverage on Pieris […]